Veracyte, Inc. (VCYT)
Health Care ยท Services-Medical Laboratories
Veracyte, Inc. (VCYT) is listed on Nasdaq, where its shares have traded since October 30, 2013. SentiSense covers Veracyte, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories. Marc Stapley is its chief executive officer. The company reports 755 employees, and its corporate website is www.veracyte.com.
About Veracyte, Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Latest reported results
Veracyte Inc. reported revenue of $151.8 million for Q3 FY2026, up 15.1% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 357 institutions reported holding VCYT, with 88.9 million shares worth $5.2 billion in aggregate. The largest reported holders were BlackRock, Vanguard and FMR. Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter.
More on VCYT
- VCYT sentiment: whether news and social coverage of Veracyte, Inc. leans bullish or bearish, and the stories driving it.
- VCYT ownership: all 357 reporting institutions, plus insider and congressional trades.
- VCYT financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Veracyte, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Veracyte, Inc. do?
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer.
What sector is VCYT in?
SentiSense classifies Veracyte, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories.
Where does VCYT stock trade?
Veracyte, Inc. (VCYT) is listed on Nasdaq, where its shares have traded since October 30, 2013.
Who is the CEO of Veracyte, Inc.?
Marc Stapley is the chief executive officer of Veracyte, Inc..